Top Markets
#1 Akedo Akedo +64.92%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +48.99%
#4 Velvet Velvet +39.58%
#5 Black Phoenix Black Phoenix +34.15%
#6 Cross Cross +32.99%
#7 Cap Cap +29.09%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.02%
#9 DoubleZero DoubleZero +13.10%
#10 Humanity Humanity +11.79%
Coin of the day
Akedo Akedo
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Classement en actions #39100
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Prix de l'action
$0.02243487
Dernière synchronisation: 2025-06-04
Capitalisation boursière
$650.09K
Changement (1 jour)
0.39%
Changement (1 an)
0.00%
Pays
SE
Échange Lipidor AB (publ) (LIPI)

Catégorie

Healthcare
EPS pour Lipidor AB (publ) (LIPI)
EPS au December 2024 TTM : $-0.01
Selon les derniers rapports financiers et le cours de l'action de Lipidor AB (publ), l’EPS actuel de la société (TTM) est de $-0.01. À la fin de 2023, la société avait un EPS de $-0.04 une diminution par rapport à celui de 2022, qui était de $-0.14.
Historique de l'EPS de Lipidor AB (publ) de 2016 à 2026
EPS à la fin de chaque année
Année EPS Changez
2026 (TTM) $-0.01 -92.68%
2024 0.00 -92.68%
2023 $-0.04 -70.93%
2022 $-0.14 66.50%
2021 $-0.08 2.38%
2020 $-0.08 9.75%
2019 $-0.07 54.89%
2018 $-0.05 125.96%
2017 $-0.02 -29.97%
2016 $-0.03 0.00%
EPS pour des entreprises ou concurrents similaires
Entreprise EPS Différence d’EPS Pays
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $29.85 -328,121.98%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $8.65 -95,154.95%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $3.55 -39,110.99%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $20.39 -224,154.95%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $1.26 -13,946.15%
US